Quick Takeaways: Why It Matters? Boehringer Ingelheim and Eko are turning every canine auscultation into a structured, AI‑backed cardiac assessment, using Eko Vet+ | CANINEBEAT AI to detect and grade heart murmurs with over 95% sensitivity and specificity against murmurs linked...
Quick Takeaways: Why It Matters? Lenzelta gives Boehringer Ingelheim a next‑generation mastitis vaccine that fits neatly into dry‑off protocols: two intramuscular doses in late gestation deliver early‑onset immunity and up to six months...
Quick Takeaways: Why It Matters? The EUAs immediately expand the therapeutic toolkit for a serious, fast-moving parasitic threat, positioning NexGard and NexGard COMBO as go‑to options if New World screwworm spreads beyond current foci in northern Mexico.&nb...
Quick Takeaways: Why It Matters? The EUA gives producers and vets a vetted, over‑the‑counter preventive option at key intervention points (birth, castration, wounds), strengthening biosecurity plans if New World screwworm encroaches toward US herds. Fo...
Quick Takeaways: Why It Matters? Full approval and label expansion make Vetmedin the standard of care for early-stage MMVD, locking in pimobendan as the only FDA‑approved option for delaying CHF in Stage B2 dogs and driving guideline‑aligned, earli...
Revenue: $5.4M Founded Year: 1982 Market Cap: 54.85M Total Employees: ~70 Headquarters: Maine, United States Stock Exchange: NASDAQ ImmuCell is an animal health company that aims towards the development, manufacturing, and marketing of scientifically-proven products that improve health and...
